Author:
Akyuz Enes,Eyvazova Habiba
Publisher
Springer Nature Singapore
Reference76 articles.
1. Allen NM, Weckhuysen S, Gorman K et al (2020) Genetic potassium channel-associated epilepsies: clinical review of the Kv family. Eur J Paediatr Neurol 24:105–116. https://doi.org/10.1016/j.ejpn.2019.12.002
2. Askland K, Read C, O’Connell C et al (2012) Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing. Hum Genet 131(3):373–391. https://doi.org/10.1007/s00439-011-1082-x
3. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217
4. Belle A, Lin W, McLaughlin J et al. (2020) ETX101, A GABAergic interneuron selective AAV- mediated gene therapy for the treatment of SCN1A Dravet syndrome: biodistribution and safety in non-human primates. AES 2020 Annual Meeting Abstract Database Abst. 391
5. Benkert J, Hess S, Ro S et al (2019) Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease. Nat Commun 10(1):5094. https://doi.org/10.1038/s41467-019-12834-x